Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.
Financial Results:
- Morepen Laboratories Ltd reported Revenues for Q2FY24 of ₹422.00 Crores up from ₹403.00 Crore year on year, a rise of 4.71%.
- Total Expenses for Q2FY24 of ₹396.00 Crores up from ₹381.00 Crores year on year, a rise of 3.94%.
- Consolidated Net Profit of ₹21.00 Crores up 31.25% from ₹16.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹0.42, up 35.48% from ₹0.31 in the same quarter of the previous year.